Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Casein kinase 1 gamma 2 antisense RNA 1 (CSNK1G2-AS1) is a long non-coding RNA highly expressed in the testis and downregulated in TGCTs, where it regulates migration, invasion, apoptosis, EMT, and AKT signaling. Its methylation state correlates with TGCT prognosis.
Not applicable; there are currently no drugs known to target CSNK1G2-AS1
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Casein kinase 1 gamma 2 antisense RNA 1 (CSNK1G2-AS1).